Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts (Q43819619)
Jump to navigation
Jump to search
scientific article published in December 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts |
scientific article published in December 2001 |
Statements
1 reference
Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts (English)
1 reference
Estey EH
1 reference
Thall PF
1 reference
Cortes JE
1 reference
Giles FJ
1 reference
O'Brien S
1 reference
Pierce SA
1 reference
Wang X
1 reference
Kantarjian HM
1 reference
Beran M
1 reference
1 December 2001
1 reference
Identifiers
1 reference